PharmaCorp RxTSXV:PCRX 35 Current Ratio is 9.42 as of Mar. 2026, which is 77% below its 10-year median of 40.58. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, PharmaCorp Rx ranks better than 95.74% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. PharmaCorp Rx's current ratio for the quarter that ended in Mar. 2026 was 9.42.
PharmaCorp Rx has a current ratio of 9.42. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for PharmaCorp Rx's Current Ratio or its related term are showing as below:
TSXV:PCRX'
s Current Ratio Range Over the Past 10 Years
Min: 2.53 Med: 40.58 Max: 341
Current: 9.42
During the past 5 years, PharmaCorp Rx's highest Current Ratio was 341.00. The lowest was 2.53. And the median was 40.58.
TSXV:PCRX's Current Ratio is ranked better than 95.74% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs TSXV:PCRX: 9.42
PharmaCorp Rx (TSXV:PCRX) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
PharmaCorp Rx Current Ratio Related Terms
PharmaCorp Rx Current Ratio Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's Current Ratio distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaCorp Rx (TSXV:PCRX) has a Current Ratio of 9.42 as of Mar. 2026. This is 77% below median its historical median of 40.58. Over the past decade, PharmaCorp Rx's Current Ratio has ranged from 2.53 to 341.00. According to the industry distribution chart, PharmaCorp Rx ranks #29 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 4.3%.
Is PharmaCorp Rx's Current Ratio too high?
PharmaCorp Rx's current Current Ratio of 9.42 is 77% below median its 10-year median of 40.58. Over the past 10 years, this metric has ranged from a low of 2.53 to a high of 341.00. The Healthcare Providers & Services industry median Current Ratio is 1.47. PharmaCorp Rx's value of 9.42 is 540.8% above this industry median. Based on the distribution chart, PharmaCorp Rx ranks #29 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Current Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #29 out of 681 companies for Current Ratio. This places PharmaCorp Rx in the top 4% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. PharmaCorp Rx's value of 9.42 is 540.8% above this benchmark. Historically, PharmaCorp Rx's own Current Ratio has ranged from 2.53 to 341.00 over the past decade. While the company's 10-year median is 40.58 vs. the industry median of 1.47, PharmaCorp Rx has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaCorp Rx's current Current Ratio of 9.42 is 540.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCorp Rx's current Current Ratio is 9.42, which is 77% below median its own 10-year median of 40.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Current Ratio of 9.42. The current Current Ratio is 9.42, which is 77% below median its 10-year median of 40.58 and 540.8% above the Healthcare Providers & Services industry median of 1.47. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Current Ratio is 9.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score
Get the complete analysis for TSXV:PCRX
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
